Physician profile
Dragos M Munteanu
NPI 1710922893
$2,119.19
in general payments reported to CMS, 2019-2025
17 companies · $520 in 2025
The $520 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2020: $56.82 · 2021: $84.10 · 2022: $409 · 2023: $352 · 2024: $120 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $992.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $653.49 | 2019-2025 | Tezspire, Fasenra |
| Janssen Pharmaceuticals, INC | $227.93 | 2020-2023 | Xarelto |
| Pfizer INC. | $186.92 | 2019-2023 | |
| Abbvie INC. | $177.95 | 2021-2025 | |
| Ucb, INC. | $156.03 | 2022-2023 | Briviact |
| Regeneron Healthcare Solutions, INC. | $98.48 | 2024 | Dupixent |
| Alexion Pharmaceuticals, INC. | $96.58 | 2021-2023 | Ultomiris |
| Csl Behring | $87.35 | 2022-2023 | Kcentra |
| Mylan Specialty L.P. | $83.59 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $82.76 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.60 | 2019 | |
| Insmed, INC. | $47.97 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $38.35 | 2020-2025 | Eliquis |
| Ekos Corporation | $36.55 | 2019 | |
| Allergan, INC. | $26.69 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $19.34 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.61 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dragos Munteanu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.